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Aqueous humorAdenylyl cyclases (ACs) are a family of enzymes which convert ATP to cAMP, an essential intermediate in many
signal transduction pathways. Of the 10 AC genes inman, 9 fall into the category of transmembrane ACs (tmACs),
which associate with G-protein coupled receptors (GPCRs) and are activated by forskolin. The 10th AC, termed
soluble AC (sAC) is neither activated by forskolin nor does it interact with GPCRs. Rather, sAC can be found in
many compartments within the cell and is activated by bicarbonate. As such, sAC is considered a major sensor
of bicarbonate in many tissues. The pathways involving sAC vary in different tissues and organ systems, and
are as diverse as facilitating sperm capacitation and regulating pressure in the eye. The role of sAC in the eye
has only recently begun to receive signiﬁcant attention. Here we summarize what is known about the roles of
sAC in the eye. This article is part of a Special Issue entitled: The role of soluble adenylyl cyclase in health and
disease.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
ACs are a family of enzymes that catalyze the conversionof adenosine-
5′-triphosphate (ATP) to cyclic adenosine 3′, 5′monophosphate (cAMP)
[1]. In mammals, there are 10 distinct AC genes [1]. Nine of these encode
transmembrane adenylyl cyclases (tmACs) which exhibit differential ex-
pression patterns, are stimulated by forskolin, and physically and func-
tionally interact with G-protein coupled receptors (GPCRs) [2–4]. The
tenth AC gene encodes the most evolutionarily conserved but most re-
cently identiﬁed member of the AC family; soluble adenylyl cyclase
(sAC) [5]. Theodor Braun ﬁrst reported soluble AC activity in rat testis in
1975 [6]. Initially this was predicted to result from the activity of the
well-known tmACs. Over twenty years later, the laboratory of Jochen
Buck and Lonny Levin succeeded in isolating sAC and cloning the gene
demonstrating that sAC is a unique enzyme that does not interact with
GPCRs and is not activated by forskolin [5]. Instead, sAC is activated by bi-
carbonate and requires a divalent cation such as Ca2+ for its
activity [7–13]. There are at least two sAC isoforms generated through al-
ternative splicing that have different regulatory characteristics. sAC is
expressed in many different cell types and can be localized anywhere in
the cell [2,6,7,14–20]. It's involvement in a wide array of signaling path-
ways inmultiple organ systems has only recently begun to gain attention
[14,17,20–24]. But in the end sAC is always functioning as a sensor of
HCO3− and affecting the pathways it interacts with based on local HCO3−
concentration [11].e of soluble adenylyl cyclase in
gy,Mayo Clinic, Guggenheim9-
07 284 2248.In the eye the metabolic needs of the various tissues that form the
optical system necessary for vision vary. Some tissues in the eye like
the cornea and lens are avascular [25], others are among the most met-
abolically active in the body. The need for aHCO3− sensor in eye tissues is
obvious, however, the role of sAC in the eye and the pathways in which
it participates have not been extensively studied. One can imaginemany
reasonswhy various ocular tissuesmight require regulation in response
to changes in the local concentration of HCO3−. For example, the concen-
tration of CO2/HCO3− in the retina varies greatly depending on light [26,
27]. Our laboratory has been interested in understanding themany roles
of sAC in the eye. Here wewill reviewwhat is known about sAC and oc-
ular physiology.2. sAC expression in the eye
The ﬁrst identiﬁcation of sAC in the eye was in the corneal endothe-
lia (CE) by Sun et al. in 2003 [28]. Since then several groups have report-
ed on the expression of sAC in various ocular tissues [15,16,29–31].
However, no systematic study of sAC activity or expression has been un-
dertaken in the eye to date. We performed a comprehensive sAC ex-
pression proﬁle in the mouse eye by immunoﬂuorescence staining.
Staining of sAC was abundant in most ocular tissues including the cor-
nea, the ciliary body, and the retina. In the lens, sAC was observed in
the epithelial cells lining the anterior surface of the lens, but not in the
ﬁber cells. We did not note signiﬁcant staining of the choroid, or sclera,
and staining was absent from drainage tissues (trabecular meshwork
and Schlemm's canal) [16]. These data conﬁrm that most of the major
sites of sAC activity in the eye (ciliary body, cornea, and retina) have
been identiﬁed and conﬁrmed using enzymatic assays for sAC activity.
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several layers of the neurosensory retina.
2.1. sAC in the cornea
The cornea is a clear avascular structure through which light enters
the eye. It is comprised primarily of the stroma, a connective tissue
which is rich in collagen and proteoglycans [32]. The outer layer of the
cornea is a non-keratinized stratiﬁed epithelium which is continuously
renewed [32]. Lining the inner surface of the stroma is the corneal endo-
thelium (CE) [33]. The CE forms a monolayer of hexagonally shaped
cells that play an indispensable role inmaintaining the proper hydration
of the stroma, without which, the transparency of the cornea cannot be
maintained [32,34,35]. As shown in Fig. 1, sAC is expressed by cells in all
three layers. The role of sAC in the cornea however, has been examined
only for the CE [36].
The CE forms a leaky barrier allowing nutrients from the aqueous
humor to pass into the corneal stroma [35]. Proper hydration however,
requires the CE to continuously pump H2O out of the stroma, a process
that is stimulated byHCO3− and follows a Cl− gradient [37]. In 2003, Sun
et al., demonstrated the presence of sAC in primary cultures of bovine
corneal endothelial cells [28]. In that study, sAC was found distributed
evenly throughout the cytoplasm of CE cells [18]. HCO3− treatment re-
sulted in an increase in cAMP production measured in the presence of
the phosphodiesterase inhibitor rolipram [28]. This correlated with a
78% increase in apical Cl− permeability in the cells, which was deter-
mined to occur through the activation of the cystic ﬁbrosis transmem-
brane conductance regulator (CFTR) [28]. As ﬂuid transport is coupled
to bothHCO3− and Cl− gradients, these data implicate sAC as a potential-
ly important player in maintaining corneal transparency by regulating
Cl− secretion in the CE in response to changes in HCO3−.
CE cell density drops progressivelywith age. During one's lifetime the
density of CE cells can drop froman average of 5500 cells/mm2 at birth to
as low as 400–700 cells/mm2 without diminishing corneal transparency
[38,39]. CE cells do not undergo mitosis in vivo [40]. Excessive loss of CE
due to surgery, trauma, or disease, can cause a loss of corneal opacity. Li
et al., demonstrated that HCO3− promotes corneal epithelial cell survival
when the cells are exposed to a pro-apoptotic stimulus [36]. Sun et al.
found that sAC expression in CE at both the mRNA and protein levels is
regulated by HCO3− in a dose and time dependent manner [18]. In most
cells cAMP is anti-apoptotic [41], and the levels of cAMP in CE are elevat-
ed in response to the HCO3− [29]. The anti-apoptotic effect of HCO3−was
signiﬁcantly reduced in cells in which sAC was reduced using siRNA, or
treated with 2-hydroxyestradiol (2HE), a non-speciﬁc sAC inhibitor im-
plicating sAC as important in the protection and survival of CE cells [29,
36].
2.2. sAC in the retina
The retina is located in the posterior eye and is comprised of the pho-
toreceptive cells and various layers of neurons and glia. These layers are
shown in Fig. 2. Immunostaining of the retina for sAC indicates that theFig. 1.Expression of sAC in the cornea. Nucleiwere stainedwithDAPI (A). Staining for sAC in the
a differential interference contrast image of the same ﬁeld (C) reveals that sAC is expressed inenzyme is expressed throughout its various cell layers. Although cAMP
plays a multitude of roles in regulating various aspects of vision, notably
on cell survival [42,43], the role of sAC in the retina is for the most part
unknown. Most work on retinal sAC has centered on its function in ret-
inal ganglion cells (RGCs) [15,31]. RGCs are the neurons that connect
the retina to the brain. Their perikarya are found in the ganglion cell
layer of the retina, and their axons comprise the optic nerve. Most
RGCs synapse in the lateral geniculate nucleus, though RGCs involved
in circadian functions and pupillary reﬂexes terminate elsewhere in
the brain [44,45]. RGC death is the reason for vision loss in glaucoma
[46], a disease that causes vision impairment in 2.7 million Americans
over the age of 40.
A number of laboratories have reported that cAMP is critical to RGC
survival and axonal growth [47–50]. Theﬁrst report of a potential role of
sAC in RGCs came in 2009. Dunnet al., examined the roles of speciﬁc ACs
and phosphodiesterase inhibitors in Ca2+-dependent protein kinase A
(PKA) activation in RGCs [31]. Ca2+-dependent PKA activation has
been reported to be involved in neuronal survival, and axonal growth
and ﬁne tuning. They found that Ca2+-dependent PKA transients are
retained even during blockade of transmembrane ACs suggesting a
role for sAC in PKA activation. However, the speciﬁc role of sAC was
not investigated in that study.
Corredor et al., hypothesized that sAC generated increases in cAMP
could underlie the survival and axon growth effects of cAMP in RGCs
[15]. To test this they applied HCO3− or electrical stimulation to cultured
RGCs and measured survival and axonal growth. HCO3− was found to
increase axon growth but had no effect on survival. In contrast to
HCO3− electrical stimulation had a positive effect on RGC survival. Similar
results were obtained when sAC was inhibited with KH7 or 2HE, or
knocked down using anti-sAC siRNA. Interestingly, inhibitors of
tmACs had no effect on survival or axonal growth of RGC cultures from
C1/AC8 double KO mice, though the competitive PKA inhibitor H89 did
conﬁrm the hypothesis of Dunn et al., [31] indicating that tmACs may
be less important than sAC in mediating RGC cell growth and survival.
To further test this, Corredor et al., examined the effect of KH7 on
RGC survival in adult rat retinas [15]. Injection of KH7 signiﬁcantly re-
duced the number of RGCs in the retina after 5 days, although when
the same experimentwas performed following optic nerve crush injury,
no effect of KH7 was observed. Examination of sAC expression 6 days
after optic nerve crush indicated that sAC had been down-regulated in
response to the injury. The authors conclude that sAC elevates cAMP
in RGCs and is required for RGC survival.
Although all work on retinal sAC has centered on its role in RGCs,
sAC is expressed by other retinal neurons including photoreceptors
and by the RPE as well. Similar to RGCs, a role for cAMP in photore-
ceptor survival has been reported [51] though it is not known if
sAC is the physiological source. Photoreceptor metabolic activity
varies greatly in dark versus light, resulting in dramatic changes in
CO2/HCO3− concentration in the outer retina. Excess CO2/HCO3− is
transported out of the retina by the RPE [52–54]. Determining
whether there is a signiﬁcant role for sAC in helping the retina adjust
to the changes in CO2/HCO3− occurring in light and dark is a topic
worthy of future investigation.corneawith a sAC speciﬁcmonoclonal antibody (B).Mergingof sAC andDAPI stainingwith
cells throughout the cornea.
Fig. 2. Expression of sAC in the retina. Differential interference contrast image (A) shows various layers of the neurosensory retina, choroid (Ch), and sclera (Sc). Cellular components of
these layers are identiﬁed by nuclear staining with DAPI (B). Staining for sAC using a sAC speciﬁc monoclonal antibody (C) reveals expression throughout the layers of the neurosensory
retina and the retinal pigment epithelium (RPE). Merging the images (D) shows that sAC (red) is highly expressed in the retina and RPE, but little sAC staining is present in the choroid or
sclera. Ph = photoreceptors; OPL = outer plexiform layer; INL = inner nuclear layer; IPL = inner plexiform layer; GCL = ganglion cell layer.
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The ciliary body is a triangular shaped region of the eye that lies be-
tween the scleral spur and the retina. It plays a role in accommodation
and also the generation of aqueous humor (AH). The AH provides nour-
ishment to the avascular tissues (cornea and lens) of the anterior cham-
ber of the eye. AH is continually produced and drained from the eye.
These pathways termed “inﬂow” and “outﬂow” pathways, respectively,
generate intraocular pressure (IOP) through the resistance to the drain-
age of AH. A healthy IOP (~15mmHg) is required tomaintain the shape
and optical properties of the eye [55]. Although glaucoma is a disease
that results from the death of retinal ganglion cells, the only effective
treatment for glaucoma is to lower IOP [46]. For this reason the physiol-
ogy of the ciliary body and the control of AH dynamics is an area that has
received a great deal of attention.
It has long been known that HCO3− and cAMP play important roles in
regulating IOP [56–62]. AH is generated by the pigmented epithelial
cells (PEs) and non-pigmented epithelial cells (NPEs) of the ciliary pro-
cesses (Fig. 3A). Among the many agents that reduce AH secretion is
forskolin [63] suggesting that cAMP diminishes AH production. Similar-
ly, cAMP is known to facilitate drainage by the conventional outﬂow
pathway [57,64–68]. This pathway is pressure responsive and is formed
by the trabecular meshwork and Schlemm's canal. In 1993, Mittag et al.
reported a HCO3− sensitive adenylyl cyclase (AC) activity in the rabbit
ciliary body [17]. Following our identiﬁcation of sAC in the ciliary epi-
thelia as the enzyme responsible for this activity [16] (Fig. 3),
Shahidullah et al. [24] demonstrated that sAC participates in the regula-
tion of pH in ciliary epithelial cells and that this function is altered in re-
sponse to acetazolamide, a carbonic anhydrase inhibitor. Application of
acetazolamide to the eye results in a decrease in IOP due to a diminished
rate of AH production.While sAC is not linked to the formation of aque-
ous humor, Shahidullah et al., did show that cAMP was elevated in NPE
cells following acetazolamide treatment and that this elevation of cAMP
was sensitive to HCO3− and the sAC inhibitor KH7. The downstream ef-
fect of the sAC mediated increase in cAMP was enhanced H+ transport.
We became interested in the role of sAC in the ciliary body as a result
of ourwork on Bestrophin 2 (Best2) [69–71]. The bestrophins are a fam-
ily of integral membrane proteins that function as anion channels
[72–78]. There are 4 bestrophins in the human genome. Only two,
Best1 and Best2 are known to be expressed in the eye, and Best2 isFig. 3. Expression of sAC in the ciliary body. Differential interference contrast image of themous
monoclonal antibody (C). Merging of the images (D) reveals expression in the epithelial cells oonly expressed by the non-pigmented epithelium (NPE) of the ciliary
body [69,70,79,80]. Since Best2 functions as a bicarbonate channel
[71], we hypothesized that IOP in Best2−/− mice would be increased
due to an increase in bicarbonate in NPE cells lacking Best2. However,
Best2−/−mice displayed a signiﬁcantly lower IOP than their Best2+/+
WT littermate controls [70]. A comprehensive examination of aqueous
dynamics in the mutant mice revealed that they do produce increased
aqueous humor when compared to Best2+/+ littermate controls [70].
However, conventional and uveoscleral drainage of AH in Best2−/−
mice increased sufﬁciently to overcompensate for the increase in AH
generated [70]. Since Best2 is found only in the ciliary body, and there
were no noticeable anatomic changes in the anterior chamber of the
Best2−/− mice, we concluded that there must be a mechanism for
pressure-independent, biochemical communication between the in-
ﬂow and outﬂow pathways.
Since Best2 is a HCO3− channel we reasoned that this activity is likely
due to sAC and that it could play a role in the communication between
the ciliary body and drainage tissues. Enzyme assays conﬁrmed the
presence of a HCO3− inducible, KH7 sensitive adenylyl cyclase activity
indicating expression of sAC in the ciliary body, which was conﬁrmed
by immunoprecipitation and Western blot [16]. Immunoﬂuorescence
staining demonstrated that sAC is localized to the PEs and NPEs of the
ciliary processes (Fig. 3).
To test the hypothesis that sAC in the ciliary body is a mediator of
outﬂow resistance, we administered the sAC speciﬁc inhibitor KH7 to
mice by intraperitoneal injection and measured changes in IOP and
episcleral venous pressure (EVP) 2 h after the injection [16]. We found
that wild-type mice treated with KH7 showed a N40% increase in IOP
but no increase in EVP, indicating that the effect of KH7 was speciﬁc to
the formation and/or drainage of aqueous humor [16]. Best2−/−mice
injected with KH7 exhibited a N45% increase in IOP–EVP in comparison
to controls [16]. To elucidate the mechanism behind this IOP increase
we measured the effect of KH7 on inﬂow and outﬂow in mice. We
found that KH7 caused a ~50% decrease in conventional outﬂow com-
pared to controls. However, therewas no statistically signiﬁcant change
in inﬂow. Uveoscleral outﬂow was increased about 16% in KH7 treated
mice over controls, a difference within the range of our experimental
error [16]. No sAC enzyme activity or immunoreactivity was observed
in drainage tissues [16]. These data suggested that sAC in the ciliary
body plays a signiﬁcant role in the regulation of outﬂow resistance,e ciliary body (A) and cell nuclei stainedwith DAPI (B). Staining for sACwith a sAC speciﬁc
f the ciliary processes.
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To further test the hypothesis that sAC in the ciliary body played a
role in the regulation of outﬂow resistance, we studied aqueous
humor dynamics in Sacytm1Lex/tm1Lexmicewhich lack the C1 catalytic do-
main of sAC. We found that Sacytm1Lex/tm1Lex mice exhibit a higher IOP
and higher outﬂow resistance than wild type littermate controls [16].
However, as would be expected in mice lacking sAC, KH7 had no signif-
icant effect on these parameters in Sacytm1Lex/tm1Lex mice [16]. These re-
sults strongly suggest that sAC is a critical regulator of IOP and provide
very strong evidence for the existence of a biochemical pathway for
communication between the CB and drainage tissues that is regulated
byHCO3− and cAMP. The results of sAC inhibition on IOP and outﬂow fa-
cility show the clearest evidence to date that a communicative pathway
must exist between the ciliary body and drainage tissues for regulating
outﬂow facility independent of pressure, and suggest new areas for
therapeutic intervention for the regulation of IOP in the treatment of
glaucoma.
3. Concluding remarks
The eye is a complex sensory organ with tissues that form a living
optical system capable of focusing and detecting light, and transmitting
that information to the brain. The metabolic needs of the various ocular
structures are highly variable. As such, one can easily envision the need
for a cellular HCO3− sensor and how critical it would be in maintaining
an environment conducive to vision. As we have seen, in CE cells and
RGCs sACpotentially plays a fundamental role in cell survival. In the cor-
nea and ciliary body sAC also seems to regulate ﬂuid and ion transport,
and in the ciliary body, sAC plays a role in a paracellular signaling path-
way that regulates outﬂow resistance. The role of sAC in regulating out-
ﬂow resistance and in the survival of RGCs and CE cells suggests that
pathways dependent on sAC might be worthy targets for therapies in
glaucoma and corneal disease.
sAC is broadly expressed in ocular tissues. It is likely thatmany of the
roles of sAC in the eye have yet to be elucidated. In the cornea sAC is
highly expressed in the stratiﬁed epithelia that form the outer corneal
surface, but its role there is unknown. sAC is expressed in all layers of
the retina but only in RGCs has its role been tested experimentally.
Considering the changes in metabolic rate that occur in the retina in
response to light, it would seem that sAC could play a number of impor-
tant, but as yet unrecognized roles. The importance of the very few
pathways already identiﬁed in the eye in which sAC is a player suggests
that futurework in this area could lead to an enhanced basic knowledge
of cAMP signaling in these tissues and potentially to the identiﬁcation of
new pathways that could be therapeutic targets in a variety of blinding
eye diseases.
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